Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (II): A pediatric drug use investigation (Q40177161)
scientific article published on November 26, 2014
Language:
Current Data About Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (II): A pediatric drug use investigation
(P31) (Q13442814)
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

(P304) 194-201
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

(P407) (Q1860)
(P887)

(P433) 3
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

(P478) 21
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

(P577) Wednesday, November 26, 2014
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

(P921) (Q412734)
(P248)
(P683) 85202

(Q27158395)
(P248)
(P683) 85196

(Q2840)
(P1932) influenza
(P3831)
(P248)
(P698) 25523716
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A25523716
(P813) Thursday, July 10, 2025

(Q102186784)
(P1932) abnormal behavior
(P3831)
(P248)
(P698) 25523716
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A25523716
(P813) Thursday, July 10, 2025

(Q7234359)
(P1932) post-marketing surveillance
(P3831)
(P248)
(P698) 25523716
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A25523716
(P813) Thursday, July 10, 2025

(P953) https://api.elsevier.com/content/article/PII:S1341321X14004024?httpAccept=text/xml
(P248)
(P356) 10.1016/J.JIAC.2014.11.009
(P854) https://api.crossref.org/works/10.1016/J.JIAC.2014.11.009
(P813) Thursday, July 10, 2025

https://api.elsevier.com/content/article/PII:S1341321X14004024?httpAccept=text/plain
(P248)
(P356) 10.1016/J.JIAC.2014.11.009
(P854) https://api.crossref.org/works/10.1016/J.JIAC.2014.11.009
(P813) Thursday, July 10, 2025

(P1433) (Q15756830)
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

(P1476) "Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigation" (language: en)
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

"Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (II): A pediatric drug use investigation" (language: en)
(P248)
(P356) 10.1016/J.JIAC.2014.11.009
(P854) https://api.crossref.org/works/10.1016/J.JIAC.2014.11.009
(P813) Thursday, July 10, 2025

(P2093) Takuji Komeda
(P1545) 1
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

Shingo Ishii
(P1545) 2
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

Yumiko Itoh
(P1545) 3
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

Yasuyuki Ariyasu
(P1545) 4
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

Masaki Sanekata
(P1545) 5
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

Takayoshi Yoshikawa
(P1545) 6
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

Jingoro Shimada
(P1545) 7
(P248)
(P698) 25523716
(P813) Monday, September 18, 2017

other details
description scientific article published on November 26, 2014

External Links
(P356) 10.1016/J.JIAC.2014.11.009
(P698) 25523716
(P8608) release_opq4c7h6c5fshevghoxra3227e